 - Presence of hepatitis B surface antigen HBsAg, positive hepatitis C antibody test result at screening or within 3 months prior to first dose of study treatment. For potent immunosuppressive agents, subjects with presence of hepatitis B core antibody HBcAb should also be excluded. 